US8753722037
US8753722037
Tandem Diabetes Care, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.12B EUR | 1.05B EUR | 1.31B EUR | 1.5B EUR |
Enterprise Value | 1.37B EUR | 1.73B EUR | 1.87B EUR | 1.85B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 101.35x | -- | -- | -- |
Price to Sales | 1.08x | 1.01x | 1.28x | 1.92x |
Price to Book | 8.59x | 8.05x | 9.92x | 9.67x |
EV/Revenue | 1.32x | 1.66x | 1.82x | 2.38x |
EV/EBITDA | -54.88x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -3.92% | -5.88% | -2.95% | -2.9% |